NeuroPace, Inc. ( NPCE) Q4 2025 Earnings Call March 3, 2026 4:30 PM EST Good afternoon, and welcome to NeuroPace Fourth Quarter 2025 Conference Call. As a reminder, this call is being recorded.
Greetings, and welcome to the Ingram Micro Fourth Quarter and Fiscal Year 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to ...
In response to the question on frequent asset restructurings, management stated, "The road to recovery, as we have discussed on past calls, is not always linear. In fact, it is rarely linear," ...
Alex Palou picked up right where he left off in 2025, opening the 2026 NTT INDYCAR SERIES season with a dominant victory in ...
1d
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing
This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.
A member’s death will likely require apportioning LLC income and may entail treatment of the interest as a sale or ...
Discover how to access company financial reports and SEC filings through investor relations sections and the EDGAR database for informed investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results